9350912007453

Lacosamide-13C,D3

https://www.novachem.com.au/web/image/product.template/370615/image_1920?unique=45cac51
SKU
L-027-1ML
UoM
1 mL
Concentration
100 ug/mL in acetonitrile
Product Brand
Cerilliant / Supelco
UNSPSC Code
41116147
Description

Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.


    This combination does not exist.

    Enquire
    Share :

    (Vimpat-13C,D3)

    No Specifications

    Please note: Chemical products listed on Novachem's website are for laboratory scientific, industrial and research use only. Products are not for human use or consumption and are not available as therapeutic agents.

    Related Articles